NASDAQ Decent Earnings on Bearish Momentum (EXPE, VRSN, CBRX, CTCT, HMSY)

New York, NY -- (SBWIRE) -- 10/26/2012 -- Expedia Inc (NASDAQ:EXPE) Expedia surged during extended trading yesterday after the company reported third quarter earnings that beat analyst estimates. Expedia sold off some during pre-market as it topped just over $60 and sold off to $59, trading at an intraday of $58.69 (+14.52%) with over 2.7million shares exchanged, will Expedia continue on this bullish momentum? Stick around.

Verisign, Inc. (NASDAQ:VRSN) Verisign strives to enable the full potential of the internet through its management of the indispensable infrastructure for .com and .net. Verisign had released third quarter financials Thursday that were above analyst expectation. Although this is good news, there is a complication with the U.S. Commerce Department not completely reviewing the company's registry agreement in time before it expires November 11th. If delayed, there will be a six month extension under terms of agreement. Verisign had bearish aftermarket/premarket movement this morning, trading at an intraday of $37.57 (-19.38%) with over 4million shares that have exchanged hands, will Verisign manage to bounce back? Stick around.

Columbia Laboratories Inc. (NASDAQ:CBRX) Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications.Columbia Laboratories today confirmed that the U.S. Food and Drug Administration (FDA) has denied Watson Pharmaceuticals’ (WPI) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA 22-139) for Prochieve for the prevention of preterm birth in women with a short cervical length. Columbia Laboratories is bearish today on the FDA denial, trading at an intraday of $.66 (-42.11%) with over 2.7million shares traded, can Columbia Laboratories bounce back on negative news? Stick around.

Constant Contact, Inc. (NASDAQ:CTCT) Constant Contact helps more than half a million small organizations connect with their customers through a suite of online engagement marketing tools. CEO Gail Goodman said the company was increasing revenue per user and retention rates although new customers were below expectations. Goodman said the transformation into a multi-product company "will take a bit longer than we had envisioned." Constant Contact is bearish today as Needham research firm downgraded the the company from a "buy to hold". Constant Contact is trading at an intraday of $12.96 (-23.90%) with over 2.8million shares exchanged, coming off the current low of day of $12.60, can Constant Contact bounce further? Stick around.

HMS Holdings Corp. (NASDAQ:HMSY) HMS Holdings Corp., through its subsidiaries, is the nation's leader in coordination of benefits and program integrity services for healthcare payers.Although HMS Holdings had decent revenues, the company has lowered it's guidance for fiscal 2012, the revenue, GAAP EPS, and EPS guidance. Now HMS Holdings has declared $600-$620million revenue for fiscal 2013, which is over analyst expectation of $502million. Trading at an intraday of $20.45 (-24.03%) with over 3.5million shares traded on bearish momentum, will HMS Holdings be able to break analyst expectation for fiscal 2013 and meet their own revenue expectations? Stick around.

View Full NASDAQ Report: http://toonicestocks.com/news/2664-nasdaq-decent-earnings-bearish-momentum-expe-vrsn-cbrx-ctct-hmsy

About TooNiceStocks.com
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on

Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.

None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.